FDA grants Beckman Coulter EUA for assay test

By LabPulse.com staff writers

October 2, 2020 -- The U.S. Food and Drug Administration (FDA) has awarded Beckman Coulter emergency use authorization (EUA) for its Access Interleukin-6 (IL-6) assay. The automated immunoassay is designed to detect IL-6 levels in serum and plasma.

The assay can be used to identify a severe inflammatory response and determine the risk of mechanical ventilation intubation in COVID-19 patients. Being able to determine this risk ensures that only patients who really need the ventilator are placed on it.

Top companies earn 80% of revenue in IVD market
Most of the revenue in the IVD market is generated by fewer than 20 companies, according to a recent report by IVD market research firm Kalorama Information,...
Beckman Coulter releases COVID-19 antibody test
Beckman Coulter has released its Access SARS-CoV-2 Immunoglobulin M assay, a new antibody test for the novel coronavirus. The assay targets antibodies...
FDA clears Beckman Coulter's automated microplate system for blood banking
Beckman Coulter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its automated microplate system and associated reagents.
Beckman Coulter secures EUA for SARS-CoV-2 test
Beckman Coulter has secured an emergency use authorization (EUA) from the U.S. Food and Drug Administration for its SARS-CoV-2 immunoglobulin G antibody...
Beckman Coulter's SARS-CoV-2 IgG assay hits CE Mark countries
Beckman Coulter announced its Access SARS-CoV-2 immunoglobulin G (IgG) assay is now available in markets that accept the CE Mark.

Copyright © 2020 LabPulse.com

Last Updated ls 10/2/2020 2:44:40 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current